17-80065510-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017950.4(CCDC40):​c.1466G>T​(p.Ser489Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00274 in 1,613,144 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S489R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 55 hom., cov: 29)
Exomes 𝑓: 0.0015 ( 52 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.71

Publications

7 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002552867).
BP6
Variant 17-80065510-G-T is Benign according to our data. Variant chr17-80065510-G-T is described in ClinVar as Benign. ClinVar VariationId is 226489.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0535 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017950.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
NM_017950.4
MANE Select
c.1466G>Tp.Ser489Ile
missense
Exon 10 of 20NP_060420.2
CCDC40
NM_001243342.2
c.1466G>Tp.Ser489Ile
missense
Exon 10 of 18NP_001230271.1
CCDC40
NM_001330508.2
c.1466G>Tp.Ser489Ile
missense
Exon 10 of 11NP_001317437.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
ENST00000397545.9
TSL:5 MANE Select
c.1466G>Tp.Ser489Ile
missense
Exon 10 of 20ENSP00000380679.4
CCDC40
ENST00000574799.5
TSL:1
n.1003G>T
non_coding_transcript_exon
Exon 6 of 16
CCDC40
ENST00000374876.4
TSL:1
c.1318-573G>T
intron
N/AENSP00000364010.4

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2238
AN:
152068
Hom.:
56
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0516
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00370
AC:
921
AN:
248758
AF XY:
0.00263
show subpopulations
Gnomad AFR exome
AF:
0.0534
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000710
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00149
AC:
2180
AN:
1460958
Hom.:
52
Cov.:
32
AF XY:
0.00120
AC XY:
871
AN XY:
726810
show subpopulations
African (AFR)
AF:
0.0556
AC:
1862
AN:
33480
American (AMR)
AF:
0.00241
AC:
108
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52568
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111952
Other (OTH)
AF:
0.00282
AC:
170
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
125
251
376
502
627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0147
AC:
2238
AN:
152186
Hom.:
55
Cov.:
29
AF XY:
0.0145
AC XY:
1081
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0515
AC:
2137
AN:
41526
American (AMR)
AF:
0.00477
AC:
73
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5106
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68026
Other (OTH)
AF:
0.0104
AC:
22
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
101
202
303
404
505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00334
Hom.:
25
Bravo
AF:
0.0169
ESP6500AA
AF:
0.0459
AC:
195
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00443
AC:
536
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser489Ile in exon 10 of CCDC40: This variant is not expected to have clinical si gnificance because it has been identified in 4.6% (195/4250) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs61739354).

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 13, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 15 Benign:2
Oct 07, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
0.074
DANN
Benign
0.62
DEOGEN2
Benign
0.34
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.55
N
PhyloP100
-1.7
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.17
Sift
Benign
0.34
T
Sift4G
Benign
0.19
T
Polyphen
0.0010
B
Vest4
0.25
MVP
0.11
MPC
0.21
ClinPred
0.010
T
GERP RS
-9.7
Varity_R
0.053
gMVP
0.070
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61739354; hg19: chr17-78039309; COSMIC: COSV99059045; API